A Drug Is Credited With Slight Gains for Patients Who Have Lung Cancer
Wednesday, June 4, 2008 - 11:49
in Health & Medicine
The drug Erbitux lengthened the survival of patients with advanced lung cancer by about five weeks, researchers have reported.
Read the whole article on NY Times Health
More from NY Times Health
Related
- Drug shrinks lung cancer tumors in miceTue, 10 Nov 2009, 13:39:02 EST
- Adding cetuximab to chemotherapy reduces advanced lung cancer death risk by 13 percentMon, 21 Sep 2009, 19:17:30 EDT
- Novel 4-drug combination proves safe for lung cancer treatmentThu, 13 Nov 2008, 10:30:54 EST
- New lung cancer research presented at CHEST 2008Tue, 28 Oct 2008, 0:36:14 EDT
- African American lung cancer patients may have different response to new cancer-fighting drugsWed, 7 Oct 2009, 18:11:47 EDT